UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 109

Sortiert nach

Onset of secondary progressive phase and long-term evolution of multiple sclerosis

Journal of neurology, neurosurgery and psychiatry, 2014-01, Vol.85 (1), p.67-75

2014

Volltextzugriff (PDF)

Smouldering multiple sclerosis: the ‘real MS’

Therapeutic Advances in Neurological Disorders, 2022-01, Vol.15, p.17562864211066751

2022

Volltextzugriff (PDF)

Age and disability accumulation in multiple sclerosis

Neurology, 2011-09, Vol.77 (13), p.1246

2011

Volltextzugriff (PDF)

The relationship of age with the clinical phenotype in multiple sclerosis

Multiple sclerosis, 2016-11, Vol.22 (13), p.1750-1758

2016

Volltextzugriff (PDF)

Pharmacological Approaches to the Management of Secondary Progressive Multiple Sclerosis

Drugs (New York, N.Y.), 2017-05, Vol.77 (8), p.885-910

2017

Volltextzugriff (PDF)

The Sylvia Lawry Centre for Multiple Sclerosis Research (SLCMSR)––Critical review facing the 20 anniversary

Multiple sclerosis and related disorders, 2022-07, Vol.63, p.103885-103885, Article 103885

2022

Volltextzugriff (PDF)

Onset of secondary progression and long-term prognosis in multiple sclerosis

Journal of the neurological sciences, 2013-10, Vol.333, p.e385-e385

2013

Volltextzugriff (PDF)

A Web-based tool for personalized prediction of long-term disease course in patients with multiple sclerosis

European journal of neurology, 2013-07, Vol.20 (7), p.1107-1109

2013

Volltextzugriff (PDF)

PAW28 The natural history of multiple sclerosis, a geographically based study. 10: relapses and long-term disability

Journal of neurology, neurosurgery and psychiatry, 2010-11, Vol.81 (11), p.e31-e31

2010

Volltextzugriff (PDF)

Correlates and trajectories of relapses in relapsing–remitting multiple sclerosis

Neurological sciences, 2024-05, Vol.45 (5), p.2181-2189

2024

Volltextzugriff (PDF)

Determinants and Biomarkers of Progression Independent of Relapses in Multiple Sclerosis

Annals of neurology, 2024-07, Vol.96 (1), p.1-20

2024

Volltextzugriff (PDF)

Analysis of clinical outcomes according to original treatment groups 16 years after the pivotal IFNB-1b trial

Journal of neurology, neurosurgery and psychiatry, 2010-08, Vol.81 (8), p.907-912

2010

Volltextzugriff (PDF)

Treatment with disease-modifying drugs for people with a first clinical attack suggestive of multiple sclerosis

Cochrane database of systematic reviews, 2017-04, Vol.4 (4), p.CD012200-CD012200

2017

Volltextzugriff (PDF)

Cross-sectional study assessing long-term safety of interferon-beta-1b for relapsing-remitting MS

Neurology, 2010-06, Vol.74 (23), p.1877

2010

Volltextzugriff (PDF)

Applied Bayesian Statistical Studies in Biology and Medicine

1, 2003

Volltextzugriff (PDF)

Reply to Oluf Anderson's reply: Predicting a window of therapeutic opportunity in multiple sclerosis

Brain (London, England : 1878), 2011-05, Vol.134 (Pt 5), p.e175; author reply e176-e175

2011

Volltextzugriff (PDF)

A W eb‐based tool for personalized prediction of long‐term disease course in patients with multiple sclerosis

European journal of neurology, 2013-07, Vol.20 (7), p.1107-1109

2013

Volltextzugriff (PDF)

The GiSAS study: Rationale and design of a pragmatic randomized controlled trial on aripiprazole, olanzapine and haloperidol in the long-term treatment of schizophrenia

Contemporary clinical trials, 2011-09, Vol.32 (5), p.675-684

2011

Volltextzugriff (PDF)

The London Ontario Database: a descriptive analysis of 25 years of follow-up

Multiple sclerosis, 2008-09, Vol.14, p.S198-S198

2008

Volltextzugriff (PDF)

The role of relapses affecting the long-term disability outcome in multiple sclerosis in the London Ontario database

Multiple sclerosis, 2008-09, Vol.14, p.S198-S198

2008

Volltextzugriff (PDF)

Splenic-gonadal fusion in cryptorchidism

European urology, 1987, Vol.13 (3), p.210

1987

Volltextzugriff (PDF)

Long-term follow-up of the original interferon-beta1b trial in multiple sclerosis: design and lessons from a 16-year observational study

Clinical therapeutics, 2009-08, Vol.31 (8), p.1724-1736

2009

Volltextzugriff (PDF)

Attributing a Paleoanthropological Specimen to a Prehistoric Population: A Bayesian Approach with Multivariate B-Spline Functions

Applied Bayesian Statistical Studies in Biology and Medicine, p.131-152

Volltextzugriff (PDF)

Age at Death Diagnosis by Cranial Suture Obliteration: A Bayesian Approach

Applied Bayesian Statistical Studies in Biology and Medicine, p.239-249

Volltextzugriff (PDF)

Some Reflections on the Current State of Statistics

Applied Bayesian Statistical Studies in Biology and Medicine, p.1-6

Volltextzugriff (PDF)

1 – 25 von 109

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(83)
Mit Volltextzugriff
(84)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Onset of secondary progressive phase and long-term evolution of multiple sclerosis

Smouldering multiple sclerosis: the ‘real MS’

Age and disability accumulation in multiple sclerosis

The relationship of age with the clinical phenotype in multiple sclerosis

Pharmacological Approaches to the Management of Secondary Progressive Multiple Sclerosis

The Sylvia Lawry Centre for Multiple Sclerosis Research (SLCMSR)––Critical review facing the 20 anniversary

Onset of secondary progression and long-term prognosis in multiple sclerosis

A Web-based tool for personalized prediction of long-term disease course in patients with multiple sclerosis

PAW28 The natural history of multiple sclerosis, a geographically based study. 10: relapses and long-term disability

Correlates and trajectories of relapses in relapsing–remitting multiple sclerosis

Determinants and Biomarkers of Progression Independent of Relapses in Multiple Sclerosis

Analysis of clinical outcomes according to original treatment groups 16 years after the pivotal IFNB-1b trial

Treatment with disease-modifying drugs for people with a first clinical attack suggestive of multiple sclerosis

Cross-sectional study assessing long-term safety of interferon-beta-1b for relapsing-remitting MS

Applied Bayesian Statistical Studies in Biology and Medicine

Reply to Oluf Anderson's reply: Predicting a window of therapeutic opportunity in multiple sclerosis

A W eb‐based tool for personalized prediction of long‐term disease course in patients with multiple sclerosis

The GiSAS study: Rationale and design of a pragmatic randomized controlled trial on aripiprazole, olanzapine and haloperidol in the long-term treatment of schizophrenia

The London Ontario Database: a descriptive analysis of 25 years of follow-up

The role of relapses affecting the long-term disability outcome in multiple sclerosis in the London Ontario database

Splenic-gonadal fusion in cryptorchidism

Long-term follow-up of the original interferon-beta1b trial in multiple sclerosis: design and lessons from a 16-year observational study

Attributing a Paleoanthropological Specimen to a Prehistoric Population: A Bayesian Approach with Multivariate B-Spline Functions

Age at Death Diagnosis by Cranial Suture Obliteration: A Bayesian Approach

Some Reflections on the Current State of Statistics

Suchergebnisse filtern